CoChat

Targeting Efflux Pumps to Overcome Antifungal Drug Resistance

Open access

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Abstract

Resistance to antifungal drugs is an increasingly significant clinical problem. The most common antifungal resistance encountered is efflux pump-mediated resistance of Candida species to azole drugs. One approach to overcome this resistance is to inhibit the pumps and chemosensitize resistant strains to azole drugs. Drug discovery targeting fungal efflux pumps could thus result in the development of azole-enhancing combination therapy. Heterologous expression of fungal efflux pumps in Saccharomyces cerevisiae provides a versatile system for screening for pump inhibitors. Fungal efflux pumps transport a range of xenobiotics including fluorescent compounds. This enables the use of fluorescence-based detection, as well as growth inhibition assays, in screens to discover compounds targeting efflux-mediated antifungal drug resistance. A variety of medium- and high-throughput screens have been used to identify a number of chemical entities that inhibit fungal efflux pumps.

Overview

Integrity signals

Registry

Crossref · 10.4155/fmc-2016-0050

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 102 references

Research works printed but not linked: 2

  1. Cannon R SklarLA LindsleyC. Phenotypic HTS multiplex for anti-fungal efflux pump inhibitors. PubChem Bioassay Screening Summary; PubChem AID 485335 (2010). http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=485335.
  2. Hartland CL , YoungsayeW, DockendorffCet al. Identification of small molecules that selectively inhibit fluconazole-resistant Candida albicans in the presence of fluconazole but not in its absence – Probe 3. In : Probe Reports from the NIH Molecular Libraries Program. Bethesda, MD (2010).

Cited by

Items 101–159 of 159

Metadata

Authors
Holmes, A. R., Cardno, T. S., Strouse, J. J., Ivnitski-Steele, I., Keniya, M. V., Lackovic, K., Monk, B. C., Sklar, L. A., & Cannon, R. D.
Affiliations
  • University of Otago (NZ)
  • The University of Melbourne (AU)
  • University of New Mexico (US)
  • New Mexico Center for Molecular Discovery, University of New Mexico, Albuquerque, New Mexico, USA
Corresponding author
Cannon, Richard D
Venue
Future Medicinal Chemistry
Published
2016-07-27
Volume
8
Issue
12
Pages
1485-1501
ISSN
  • 1756-8919 (ISSN-L)
  • 1756-8927
OpenAlex
W2478702959
Cited by
156
References
102
Citations by year
2026: 20 · 2025: 24 · 2024: 18 · 2023: 24 · 2022: 16 · 2021: 14 · 2020: 18 · 2019: 10 · 2018: 6 · 2017: 6
FWCI
1.13
Type
journal article
Language
en
Open access
Locations
  • Future Medicinal Chemistry (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (R01-DE016855-01; R03-MH087406-1A1)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Keywords
antifungal resistance, efflux pumps, Candida, chemosensitization, combination therapy, heterologous expression in Saccharomyces cerevisiae, fluorescence-based screening, high-throughput screening, drug discovery
MeSH terms
Antifungal Agents, Azoles, Fungi, Humans, Microbial Sensitivity Tests, Mycoses, Drug Resistance, Fungal, Membrane Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.